A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.57 USD -5.38% Market Closed
Market Cap: 416.1m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Aquestive Therapeutics Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
Total Liabilities & Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Total Liabilities & Equity
$117.6m
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Liabilities & Equity
$178.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities & Equity
$93.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Liabilities & Equity
$216.2B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Liabilities & Equity
$117.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Liabilities & Equity
$75.6B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
8%

See Also

What is Aquestive Therapeutics Inc's Total Liabilities & Equity?
Total Liabilities & Equity
117.6m USD

Based on the financial report for Jun 30, 2024, Aquestive Therapeutics Inc's Total Liabilities & Equity amounts to 117.6m USD.

What is Aquestive Therapeutics Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
18%

Over the last year, the Total Liabilities & Equity growth was 106%. The average annual Total Liabilities & Equity growth rates for Aquestive Therapeutics Inc have been 21% over the past three years , 18% over the past five years .

Back to Top